Milestone filed an offering pursuant to an SEC registration statement, with TD Cowen acting as joint book-running manager.
1 report, 1 independent
Updated Jul 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Milestone filed an offering pursuant to an SEC registration statement, with TD Cowen acting as joint book-running manager.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- TD Cowen provided analyst ratings and price targets for Ardelyx, accompanied by required stock transaction filings with the SEC.
- TD Cowen is managing a share offering for PMV Pharma, which has been filed with the SEC and utilizes Broadridge Financial Solutions for mailing the prospectus.
- TD Cowen issued a buy rating and price target for Evolv Technologies Holdings, Inc.
- DTE Energy filed disclosures with the SEC and TD Cowen began covering its stock.
- TD Cowen and Royal Bank of Canada published research reports on ChargePoint shares.
Coverage
Newest first; wire copies grouped- GlobeNewswireMilestone Pharmaceuticals Announces Proposed Public Offering MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today